Join us in celebrating Rare Disease Day 2021!

Developing treatments for rare diseases is a complex process. We’re committed to helping biotech and pharma fulfill the unmet needs that often accompany diseases affecting fewer than 1 in 2000 people.

Rare disease trials require special considerations for overall regulatory strategy, patient recruitment, data navigation, and market access to name a just few.  Certara’s experts use cutting edge biosimulation and regulatory science to help our partners get these critical medicines into the hands of patients who need them.

Check out these resources illustrating our extensive impact on Rare Disease Programs:

Rare Disease and Orphan Drug Development

Making Sense of 6MWT Variability: Developing a Disease Progression Model for DMD

How to Expedite FDA Approvals of Orphan Drugs


Powered by GlobalLink OneLink Software